Hepato-biliary stem cells: facts and fancies by Neil D Theise
MEETING ABSTRACT Open Access
Hepato-biliary stem cells: facts and fancies
Neil D Theise
From 1st International Conference of Collaborative Research Center 974: Liver Damage and Regeneration
Düsseldorf, Germany. 15-16 November 2013
The canals of Hering and stem cells
At the close of the 20th century, a decades long questions
was finally settled: both rodent and human livers had
facultative hepato-biliary stem cells. The stem cell niche in
which these cells’ activities were identified was the canal of
Hering (CoH) [1] – the link between hepatocyte canaliculi
and the biliary tree. This structure had been functionally
demonstrated by Ewald Hering in 1857, but its anatomic
structure was merely inferred, but not visualized. Hering’s
suggested that the link was located at the limiting plate,
where hepatic parenchyma encountered portal tract
stroma. His initial drawings depicted that hypothesis. The
first direct imagings of the CoH were via electron micro-
scopy, which confirmed that the CoH, as Hering intuited,
was comprised of hepatocytes on one side and the smallest
cholangiocytes on the other, but these high powered,
ultrastructural views could not really explore the canal’s
tissue level anatomic structure.
Immunohistochemistry (for biliary keratins) and serial
sectioning to create a three dimensional analysis of CoH
in human livers solved the question [2]. Human CoH were
not as small as thought and not restricted to the limiting
plate; rather, they were delicate structures that extended
across the limiting plate, into the periportal parenchymal
regions, as much as a third of the way toward the central
vein (but no further). It was from these structures that
new hepatocytes were seen to be arising in the setting of
severe acute injury (e.g. acetaminophen toxicity) [2] and in
chronic liver diseases of all kinds (reviewed in [3]).
These findings led to significant paradigm shifts. For
hepato-biliary regeneration, settling of the argument as to
whether there actually were liver stem cells potentiated
explosive creativity in exploring their physiologic behavior
and theraperutic potential. For pathology, the ubiquitous,
but poorly understood “ductular reactions” (DR) – seen in
all severe acute injuries and in all advanced stage chronic
liver disease – were now understood to be tissue activa-
tions of the hepatobiliary stem cell niche [3].
Identification of diverse hepatobiliary stem cell
niches
The state of the art for identifying stem cell niches in any
organ is called the “label retaining cell (LRC) assay” and
exploits the definitional qualities of stem cells that are
rarely dividing (“quiescent”) and productive of differentiat-
ing, rapidly proliferative, transit amplifying, progenitor
cells (the hepatobiliary cells of DR in humans, the “oval
cells” in rodents). Pulse labeling with a marker (e.g. BrdU)
or with inducible transgenic markers can lead to labeling
of nuclei of dividing stem and progenitor cells. Since tran-
sit amplifying progenitor cells are rapidly proliferative, the
label is washed out. The other daughter cell restores a
quiescent stem cell to the niche which thus, being quies-
cent, retains the label. One such study, to my knowledge,
has been published for the liver, by my own group. Kuwa-
hara et al [5], exploiting a murine model of acetaminophen
toxicity], highlighted four possible stem cell niches all of
which were predicted by other investigators in other mod-
els (see [4] for details):
• small cuboidal cells in the CoH;
• occasional cholangiocytes in the interlobular bile
ducts;
• periductal null cells (devoid of epithelial or other
stem cell markers); these were previously suggested
by work from the Sell laboratory and/or could be
related to multipotent stromal cells;
• peribiliary hepatocytes (PBH), i.e. hepatocytes that
were directly adjacent to the CoH or bile ductules
which were, to our surprise, the most commonly
found LRC in this model.
Finally, in a research field too complex and robust to
summarize here, there also appear to be extrahepatic
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stem/progenitor cells which may be, for example, circu-
lating mesenchymal stem cells, hepatopoietic stem cells
or so called “very small embryonic-like stem cells” some
or all of which may derived from niches in the bone mar-
row. This field remains highly contentious: while there is
significant (often political) opposition to these possibili-
ties, there is also still greater support in the published
evidence to date [5]. Time, of course, will tell.
The puzzles of liver reconstitution & the unique
hepatic microanatomy
One persistent question that remains, even as consensus
regarding the existence of hepatobiliary stem cells has soli-
dified, is why, unlike other organs, do these stem cells
seem not to lead to significant parenchymal reconstitu-
tion? In all injury models in mice and in acute liver disease
in humans, hepatocytes still seem to regenerate the major-
ity of the hepatic parenchyma. Only in chronic human
liver disease – and then only in the advanced (often cir-
rhotic) stages of disease progression – are significant
patches of parenchyma restored from stem/progenitors
[6,7]. Why is the liver different from almost every other
epithelial compartment in the body?
We have suggested one explanation that connects the
PBH LRC data in acetaminophen with the heretofore
unremarked, unique aspects of basement membrane
topography in the liver compared with other organs [8].
How might these relate? In all non-hepatic epithelial
compartments of the body, basement membrane is con-
tinuous around all gland duct/acinar structures. Thus,
when their stem cells produce transit amplifying progeny,
the basement membrane provides a mechanical structure
along which the cells can travel to their anatomical
homes. In the liver, however, the basement membrane,
while continuous around all biliary structures, stops and
is interrupted at the CoH. The hepatocytes, that are
directly linked to the CoH have no basement membrane,
they and all the other hepatocytes are arrayed within the
loosely aggregated collagen/reticulin fibers in the space
of Disse. Thus, in response to injury, the repopulating
hepatocytes have no guiding structure to lead them to
reconnect to the cholangiocytes of the CoH.
One explanation to solve this puzzle is that the CoH
secretes chemotactic factors which alert hepatocytes as
to where to travel (though none have been recognized).
Another possibility is that it is purely stochastic, regen-
erating hepatocytes filling the gap and eventually, ran-
domly bumping into the CoH to re-attach. Either way,
however, the hepatocytes not only have to get to the
CoH, but once there have to turn on expression of the
unique cell adhesion molecules that would allow for
direct linking to these cholangiocytes, molecules that are
very different from those that link hepatocytes to each
other.
Our third hypothesis is intermediate between these
two options [8]: that hepato-biliary stem cells are
uniquely not tasked with tissue reconstitution. Instead,
they are simply responsible for the re-establishment of
the hepato-biliary link. The stem cell, having produced a
hepatocytic neighbor, i.e. a PBH, has done its job. That
PBH is already bound to its sibling cholangiocyte/stem
cell in the CoH, but, being a hepatocyte, is also prepared
to link to any hepatocyte that arrives next door through
the stochastic movements of the repopulating hepato-
cytes. In human chronic liver disease, these PBH, even-
tually begin to contribute to significant repopulation
because the older, previously repopulated hepatocytes
become replicatively senescent. The PBH, having been
largely quiescent over time; maintain the capacity to
take over the repopulation.
We can also suggest that the basement membrane is
therefore a key regulator of hepatobiliary stem cell func-
tioning for regulating quiescent and differentiation. This
may be related to adhesion molecules linking matrix pro-
teins and cell membrane components, (e.g. integrins), but
could also relate to the mechanical properties of base-
ment membrane, such as stiffness. Testable predictions
regarding this hypothesis, including these aspects, are
currently under way.
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